Literature DB >> 8175249

Which cancer patients benefit most from a brief, group, coping skills program?

A J Cunningham1, G A Lockwood, C V Edmonds.   

Abstract

OBJECTIVE: The purpose of this study was to explore the influence of a number of variables on the improvements in quality of life of some 400 cancer patients who completed a brief, group program providing psychosocial support and training in coping skills.
METHOD: The factors tested were: patient gender, age, marital status, religion, education level, diagnostic site, recurrence status, expectations of the course, previous experience in self-help techniques, and different group leaders. Three assessment instruments were used, the Profile of Mood States (POMS), the Functional Living Index for Cancer (FLIC), and the Stanford Inventory of Cancer Patient Adjustment (SICPA). Assessments were made at three time points.
RESULTS: The overall finding was that the program improved mood and enhanced quality of life for most cancer patients: there was no evidence that it was more or less effective for subgroups based on gender, marital status, religious orientation, education level, and previous experience with mental self-help techniques. It was also found that several different group leaders with widely varying experience facilitated similar improvements. However, there was a significant tendency for patients under fifty to improve more by the end of the program, than older patients, although this difference disappeared at the three month follow-up. In addition, patients with recurrent disease showed less improvement in quality of life than those with primary cancer.
CONCLUSIONS: The beneficial effects on quality of life of a seven-session group psychoeducational program were seen across a wide range of categories of cancer patients. The generalizability and implications of these findings are briefly discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8175249     DOI: 10.2190/EQ7N-2UFR-EBHJ-QW4P

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  6 in total

Review 1.  Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome.

Authors:  Rie Tamagawa; Sheila Garland; Marcus Vaska; Linda E Carlson
Journal:  J Behav Med       Date:  2012-01-22

2.  On the generalizability of statistical expressions of health related quality of life instrument responsiveness: a data synthesis.

Authors:  M M Murawski; P A Miederhoff
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

3.  An online stress management workbook for breast cancer.

Authors:  Kelly M Carpenter; Susan A Stoner; KrisAnn Schmitz; Bonnie A McGregor; Ardith Z Doorenbos
Journal:  J Behav Med       Date:  2012-12-02

4.  Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial.

Authors:  Catherine C Classen; Helena C Kraemer; Christine Blasey; Janine Giese-Davis; Cheryl Koopman; Oxana Gronskaya Palesh; Ami Atkinson; Sue Dimiceli; Gail Stonisch-Riggs; Joan Westendorp; Gary R Morrow; David Spiegel
Journal:  Psychooncology       Date:  2008-05       Impact factor: 3.894

5.  Moderators of the effects of meaning-centered group psychotherapy in cancer survivors on personal meaning, psychological well-being, and distress.

Authors:  Karen Holtmaat; Nadia van der Spek; Birgit I Witte; William Breitbart; Pim Cuijpers; Irma M Verdonck-de Leeuw
Journal:  Support Care Cancer       Date:  2017-06-07       Impact factor: 3.603

Review 6.  Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.

Authors:  J Kalter; I M Verdonck-de Leeuw; M G Sweegers; N K Aaronson; P B Jacobsen; R U Newton; K S Courneya; J F Aitken; J Armes; C Arving; L J Boersma; A M J Braamse; Y Brandberg; S K Chambers; J Dekker; K Ell; R J Ferguson; M F M Gielissen; B Glimelius; M M Goedendorp; K D Graves; S P Heiney; R Horne; M S Hunter; B Johansson; M L Kimman; H Knoop; K Meneses; L L Northouse; H S Oldenburg; J B Prins; J Savard; M van Beurden; S W van den Berg; J Brug; L M Buffart
Journal:  Psychooncology       Date:  2018-03-15       Impact factor: 3.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.